Paul R Edick
CIK 1531178 · View on SEC EDGAR ↗
First SEC filing: Oct. 5, 2021 · Latest: Oct. 5, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 5, 2021 | XERS | A | 400,000 | — | — | 400,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 5, 2021 | XERS | A | 200,000 | — | — | 200,000 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 5, 2021 | XERS | A | 98,252 | — | — | 98,252 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 5, 2021 | XERS | A | 69,822 | — | — | 69,822 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 5, 2021 | XERS | A | 668,065 | — | — | 668,065 Direct | — | Acquired | (price as of 2026-08-20) |
| Oct. 5, 2021 | XERS | A | 13,430 | — | — | 13,430 Indirect | — | Acquired | (price as of 2026-08-20) |
| Oct. 5, 2021 | XERS | A | 410,833 | — | — | 608,064 Direct | +208.30% | Acquired | (price as of 2026-08-20) |
| Oct. 5, 2021 | XERS | A | 197,231 | — | — | 197,231 Direct | — | Acquired | (price as of 2026-08-20) |
| June 5, 2020 | MIST | A | 15,000 | — | — | 15,000 Direct | — | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (400,000) | $5.08 | Jan. 31, 2031 | 400,000 | Acquired |
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (200,000) | $13.88 | Jan. 31, 2029 | 200,000 | Acquired |
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (98,252) | $5.93 | Jan. 31, 2028 | 98,252 | Acquired |
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (69,822) | $1.55 | June 11, 2027 | 69,822 | Acquired |
| Oct. 5, 2021 | XERS | Stock Option (Right to Buy) | Common Stock (668,065) | $1.55 | Jan. 27, 2027 | 668,065 | Acquired |
| June 5, 2020 | MIST | Stock Option (right to buy) | Common Shares (15,000) | $3.74 | June 5, 2030 | 15,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $421,449 | — | $3,690,000 | $538,969 | $301,123 | — | $1,875,067 | $6,826,608 |
| 2023 | $693,934 | — | $930,000 | — | $499,632 | — | $13,200 | $2,136,766 |
| 2022 | $691,710 | — | — | — | $416,360 | — | $11,529 | $2,805,599 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.